Bone Marrow TransplantationTissue DonorsTransplantation, HomologousHistocompatibility TestingGraft vs Host DiseaseHistocompatibilityBone MarrowGraft SurvivalTransplantation ChimeraBone Marrow CellsWhole-Body IrradiationTransplantation ConditioningHematopoietic Stem Cell TransplantationTransplantation, AutologousSurvival AnalysisAnemia, AplasticHematopoietic Stem CellsLeukemiaBone and BonesGraft RejectionLiver TransplantationTransplantation, IsogeneicRadiation ChimeraGraft Enhancement, ImmunologicTransplantation ToleranceStem Cell TransplantationKidney TransplantationMice, Inbred C57BLLeukocyte TransfusionImmunosuppressive AgentsTreatment OutcomeBusulfanSkin TransplantationRecurrenceBone Marrow PurgingImmunosuppressionHLA AntigensTransplantation ImmunologyHematologic NeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiving DonorsLymphocyte DepletionChimerismStem CellsHeart TransplantationTime FactorsActuarial AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideBone Marrow DiseasesBlood DonorsT-LymphocytesHematopoiesisAcute DiseaseCombined Modality TherapyLeukemia, Myeloid, AcuteBone Marrow ExaminationLymphocyte Culture Test, MixedRemission InductionChimeraHepatic Veno-Occlusive DiseaseBone RemodelingGraft vs Host ReactionMice, Inbred BALB CBone Marrow NeoplasmsLeukemia, MyeloidLymphoma, Non-HodgkinLymphocyte TransfusionDisease-Free SurvivalColony-Forming Units AssaySevere Combined ImmunodeficiencyRetrospective StudiesMyelodysplastic SyndromesLung TransplantationSiblingsCyclosporineHematologic DiseasesFlow CytometryCell DifferentiationMice, Inbred C3HBone DensityOrgan TransplantationImmune ToleranceNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsGraft vs Tumor EffectFollow-Up StudiesCells, CulturedCarmustineSurvival RatePancytopeniaCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorSpleenLeukocyte CountCytarabineGraft vs Leukemia EffectMelphalanBone ResorptionAntigens, CD34